INTRODUCTION
============

Eosinophilic gastrointestinal disorders are a family of uncommon diseases and include eosinophilic oesophagitis, gastritis and enterocolitis. Disease typically occurs during the third to fifth decades of life^\[[@b1-586-1-3617-1-10-20170228]\]^.

The pathogenesis is not well understood, but there may be an allergic component. Histologically, disease is characterized by infiltration of the digestive tract tissues by eosinophils^\[[@b1-586-1-3617-1-10-20170228]\]^.

Clinical manifestations depend on the location, extent and layers of digestive tract involved^\[[@b1-586-1-3617-1-10-20170228]\]^. In disease restricted to the mucosa, symptoms are non-specific and abdominal pain, nausea, vomiting, diarrhoea, weight loss and malabsorption syndrome can occur depending on the area involved. Disease with muscular involvement is mainly characterized by symptoms of intestinal obstruction.

When there is involvement of the serous layer, the clinical presentation may include isolated ascites or ascites combined with symptoms described in mucosal or muscular disease. Peripheral eosinophil counts are generally increased but may be normal in 20% of cases^\[[@b1-586-1-3617-1-10-20170228]\]^.

We describe a clinical case of eosinophilic gastroenteritis with isolated involvement of the subserous layer.

CASE REPORT
===========

A 41-year-old female patient was admitted through the emergency department with increased abdominal volume, anorexia, general malaise and watery diarrhoea for 15 days before admission. The patient had a past history of autoimmune hypothyroidism medicated with levothyroxine 0.1 mg/day. She had no history of allergies, alcohol intake, ingestion of well water, contact with animals or recent trips abroad. On initial evaluation the patient was conscious and vital signs were normal. Abdominal examination showed ascites with no palpable masses or organomegaly. No peripheral oedema, stigmata of chronic liver disease or adenopathy were present. Blood tests revealed leucocytosis (12,560/μl) with 6,280 neutrophils/μl and 3,454 eosinophils/μl, C-reactive protein of 2.04 mg/dl, a sedimentation rate of 6 mm and albumin of 3.3 g/dl ([Table 1](#t1-586-1-3617-1-10-20170228){ref-type="table"}). Clear liquid obtained from diagnostic paracentesis revealed an albumin of 3 g/dl and a calculated serum albumin gradient (SAG) below 1.1 g/dl, suggesting that portal hypertension was not the cause of the ascites. The ascitic fluid (10mL) contained 15,646 cells of which 1,846 were leucocytes (neutrophils 75%, monocytes 20%, lymphocytes 5%, no description of eosinophils), total proteins 5.0 g/dl, glucose 92 mg/dl, LDH 140 IU/l, ADA 10.4 IU/l and amylase 20 IU/l. Abdominal computed axial tomography showed ascites, thickening of the walls of the stomach, duodenum and jejunum, and a suspected nodular pancreatic lesion ([Fig. 1](#f1-586-1-3617-1-10-20170228){ref-type="fig"}).

The patient was admitted to our unit and microbiological, mycobacteriological and cytological studies of ascitic fluid were requested. Blood cultures, and microbiological and parasitological stool samples were collected and ceftriaxone 2 g IV was initiated.

The patient's symptoms and ascites worsened. In light of the clinical findings, ascites with SAG \<1.1, peripheral eosinophilia and the imaging results, the differential diagnosis included gastrointestinal tract neoplasia and parasitic infections. Cytological analysis of ascitic fluid revealed inflammatory characteristics with a predominance of eosinophils but with no evidence of malignancy ([Fig. 2](#f2-586-1-3617-1-10-20170228){ref-type="fig"}). Upper and lower digestive endoscopy was normal. A biopsy of the pancreas was performed but there was no evidence of malignancy on histological examination. All microbiological studies including parasitological analysis of the faeces and serology for parasites were negative. Auto-antibodies to coeliac disease and an autoimmune study were also negative ([Table 1](#t1-586-1-3617-1-10-20170228){ref-type="table"}).

Since all studies were negative, eosinophilic gastroenteritis was considered. Upper gastrointestinal endoscopy was repeated and gastric and jejunal biopsy specimens were normal. Due to the absence of eosinophil infiltration in the biopsy specimens, paracentesis was repeated and the predominance of eosinophils in the ascitic fluid was confirmed, a distinct finding compared with the initial automated analysis that showed 75% of neutrophils, known to be a mistake after discussion with laboratory technicians. The diagnosis of eosinophilic gastroenteritis was made and, given the clinical worsening, corticosteroid therapy with prednisolone 40 mg/day was started. There was improvement and complete resolution of all symptomatology, ascites and negative analysis findings after 2 months. During follow-up consultation after corticosteroid withdrawal, clinical relapse was observed, so corticosteroid therapy was reinstated. The patient is currently corticosteroid-dependent on a daily dose of 5 mg prednisolone.

DISCUSSION
==========

Eosinophilic gastroenteritis is an uncommon disease but the diagnosis should be considered in the presence of gastrointestinal symptoms or ascites associated with peripheral eosinophilia (\>500 eosinophils/μl). The definitive diagnosis is established in the presence of eosinophilic infiltration of the gastrointestinal tract or ascites with a predominance of eosinophils^\[[@b2-586-1-3617-1-10-20170228]\]^. It is mandatory to exclude differential diagnoses^\[[@b2-586-1-3617-1-10-20170228]\]^, namely neoplasms, parasitic infections, inflammatory bowel disease, vasculitis, Langerhans cell histiocytosis and hypereosinophilic syndrome. In our patient, the analytical, microbiological and anatomopathological studies excluded most of the differential diagnoses, leaving hypereosinophilic syndrome which should always be considered in the presence of eosinophilia. This syndrome is characterized by a peripheral eosinophil count above 1,500/μl for at least 6 months and the involvement of other organs, which was not observed in this particular case.

Eosinophilic infiltration is confirmed through multiple gastric and intestinal biopsies as one is not sufficient^\[[@b3-586-1-3617-1-10-20170228]\]^. Diagnosis by biopsy is possible in 80% of patients^\[[@b3-586-1-3617-1-10-20170228]\]^. However, in isolated muscle or subserous disease, biopsies may be normal^\[[@b1-586-1-3617-1-10-20170228]\]^, which explains the absence of eosinophils in the biopsy performed in the present case, supporting the diagnostic hypothesis of isolated subserous disease.

Spontaneous remission of disease is rare. The scientific evidence regarding treatment is limited, but it is mentioned that the initial approach depends on the severity of the symptomatology. In the initial phase an elemental diet should be tried^\[[@b2-586-1-3617-1-10-20170228]\]^. In the absence of response to dietary changes or in the presence of severe symptomatology, corticosteroid therapy should be considered. Three types of response to therapy are described: (a) complete remission; (b) complete or partial remission in the initial phase but with sporadic flares of disease between months to years apart requiring transient introduction of or increased corticosteroid therapy; and (c) lack of response with a sustained need for low-dose corticosteroids. The recommended dosage in the acute phase is daily 20--40 mg prednisolone and improvement is usually seen within 2 weeks^\[[@b4-586-1-3617-1-10-20170228]\]^. After resolution of symptomatology, corticosteroid therapy should be reduced to the lowest possible dose with the objective of complete suspension.
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![Abdominal computed axial tomography showing ascites and gastric wall thickening](586_Fig1){#f1-586-1-3617-1-10-20170228}

![Histological examination of ascitic fluid showing abundant cellularity with inflammatory characteristics with a predominance of eosinophils (40× magnification)](586_Fig2){#f2-586-1-3617-1-10-20170228}

###### 

Results of blood tests and ascitic fluid analysis

  PARAMETER                             VALUE   REFERENCE VALUE   PARAMETER                                                       VALUE
  ------------------------------------- ------- ----------------- --------------------------------------------------------------- ----------
  Haemoglobin (g/dl)                    15.0    11.8--15.8        Serum IgG/IgA/IgM                                               Normal
  Mean corpuscular volume (fl)          84.4    80.4--96.4        HIV/ANA/ANCAs                                                   Negative
  Leucocytes (/μl)                      12.56   4.0--10.0         Anti-transglutaminase/antigliadin antibodies                    Negative
  Neutrophils (/μl)                     6,280   1,800--7,700      Fasciola, Histoplasma, Entamoeba, *Toxocara canis* serologies   Negative
  Eosinophils (/μl)                     3,454   \<500             Urine analysis                                                  Normal
  Platelets (×10^9^/l)                  321     150--400                                                                          
  Creatinine (mg/dl)                    0.75    0.6--1.0          Ascitic fluid analysis                                          
  Sodium (mmol/l)                       141     136--145          Cells (/μl)                                                     15,646
  Potassium (mmol/l)                    3.8     3.5--5.1          Leucocytes (/μl)                                                1,846
  C-reactive protein                    2.04    0.01--0.82        Neutrophils (%)                                                 75
  Sedimentation rate (mm/h)             6       4--10             Monocytes(%)                                                    20
  Albumin (g/dl)                        3.3     3.5--5.5          Lymphocytes (%)                                                 5
  Thyroid stimulating hormone (μIU/l)   4.42    0.35--4.94        Erythrocytes (/μl)                                              13,800
  Aspartate aminotransferase (IU/l)     18      8--35             Albumin (g/dl)                                                  3.0
  Alanine transaminase (IU/l)           24      7--45             Total proteins (g/dl)                                           5.0
  Alkaline phosphatase (IU/l)           68      30--120           Lactate dehydrogenase (IU/l)                                    140
  Gamma glutamyl transferase (IU/l)     31      \<38              ADA (IU/l)                                                      10.4
  Total bilirubin (mg/dl)               0.41    0.3--1.2          Glucose (mg/dl)                                                 92
  Lactate dehydrogenase (IU/l)          315     125--220          Amylase (IU/l)                                                  20
  Prothrombin time (sec)                10.9    11.4                                                                              
  Partial thromboplastin time (sec)     22.1    28.0                                                                              
  IgE (kU/l)                            62.1    \<100                                                                             
